Summary

Factor V Leiden is the most common inherited blood clotting disorder — carriers (CT) have a 5-10x increased risk of deep vein thrombosis and homozygotes (TT) a 50-100x risk, making this essential knowledge before surgery, long-haul travel, pregnancy, or starting estrogen-containing contraception, with straightforward risk-reduction strategies that make a real difference.

Genotype spectrum

CC (Arg/Arg — normal)

Your coagulation system self-regulates normally. APC resistance is not a concern for you.

CT (Arg/Gln — heterozygous)

Knowing this is genuinely protective. Most carriers never have a clot event — but the ones who do often had a preventable trigger (estrogen contraception, post-surgical immobility, dehydration on a long flight).

TT (Gln/Gln — homozygous)

This is one of the most actionable findings in your genetic profile. The risk is real and high, but the interventions are well-established and highly effective.

Practical takeaway

For CT Carriers (Heterozygous — Awareness and Situational Precautions)

Contraception:
• Estrogen-containing contraceptives are strongly discouraged. Combined oral contraceptive pills, patches, and rings all contain estrogen. The 30-50x VTE risk multiplication is too high.
• Alternatives: Progestogen-only pill (mini-pill), hormonal IUD (Mirena — delivers progestogen locally, minimal systemic effect), copper IUD, barrier methods. Discuss with your GP mentioning your Factor V Leiden status.
• If currently on combined oral contraceptives: don't panic, but schedule a review with your GP to discuss alternatives.

Surgery:
• Inform every surgeon and anaesthetist about your Factor V Leiden status. This is not optional.
• Prophylactic anticoagulation (usually low-molecular-weight heparin, LMWH) may be warranted for moderate-to-high-risk surgeries.
• Early mobilisation after any surgery. Compression stockings during recovery.

Travel:
• Flights >4 hours: stay hydrated (water, not alcohol), move your legs regularly (aisle seat helps), consider compression stockings.
• Long car journeys: regular breaks with walking.
• Avoid dehydration during travel — it independently increases blood viscosity.

Pregnancy:
• Discuss Factor V Leiden with your obstetrician at the first antenatal visit.
• Prophylactic LMWH may be recommended, especially in the postpartum period (highest VTE risk window).
• Monitor for signs of VTE: unilateral leg swelling, calf pain, chest pain, sudden breathlessness.

General:
• Don't smoke. Smoking compounds clotting risk. For you, this isn't just cardiovascular advice — it's thrombophilia management.
• Stay hydrated. Dehydration thickens blood. Adequate water intake is a simple, daily thrombosis-prevention measure.
• Know DVT symptoms: Unilateral leg swelling, warmth, redness, calf pain that worsens with foot flexion. Seek urgent medical attention.
• Know PE symptoms: Sudden shortness of breath, chest pain (worse on inspiration), rapid heart rate, coughing blood. This is an emergency — call 999/911.

What "working" looks like:
• No clotting events. (This is the goal — absence of pathology.)
• All healthcare providers aware of your Factor V Leiden status.
•

Evidence detail

What This Gene Does

Factor V is a clotting protein — part of the coagulation cascade that stops you from bleeding when you're injured. After a clot forms, a protein called activated protein C (APC) normally breaks down Factor V to dissolve the clot and prevent it from growing too large. The Leiden mutation (Arg→Gln at position 506) removes the exact spot where APC cuts Factor V, making Factor V resistant to being switched off. The clot-promoting signal stays active longer than it should.

The result: your blood is biased toward clotting. Not dramatically — most carriers go their entire lives without a clot. But when you add a second hit (surgery, immobility, estrogen, pregnancy, dehydration), the threshold for pathological clotting is lower than it should be.

Mechanism

The coagulation cascade is a chain of enzymatic activations that produces fibrin — the mesh that forms blood clots. Factor V is activated (to Factor Va) as part of the prothrombinase complex, which converts prothrombin to thrombin. Thrombin then converts fibrinogen to fibrin. Clot formed.

The off-switch: Activated Protein C (APC)

After a clot forms, APC is activated to prevent excessive clotting. APC cleaves Factor Va at three specific sites: Arg306, Arg506, and Arg679. The Arg506 cleavage is the critical first cut — it's the fastest and enables the subsequent cuts. Without it, Factor Va degradation is 10-20x slower.

The Leiden mutation (R506Q):

Factor V Leiden replaces Arg506 with Gln. APC literally cannot make its first cut. Factor Va persists in the prothrombinase complex, continuing to generate thrombin long after the clot should have been contained. The result is a prothrombotic state — not uncontrolled clotting, but a lower threshold for pathological clot formation.

Why carriers don't clot constantly:

Other anticoagulant pathways (antithrombin, tissue factor pathway inhibitor, protein S) still function. APC can still make the slower Arg306 cut. The system has redundancy. Factor V Leiden shifts the haemostatic balance toward clotting, but doesn't break it. Most carriers maintain adequate clot regulation under normal conditions. It takes a second hit — immobility, surgery, estrogen, pregnancy, dehydration — to tip the balance toward pathological thrombosis.

The estrogen synergy:

Estrogen independently increases production of several clotting factors (including prothrombin, Factor VII, Factor X) and decreases antithrombin and protein S. In a Factor V Leiden carrier, you now have: (1) APC-resistant Factor Va that won't turn off, AND (2) increased upstream clotting factors AND (3) decreased anticoagulant proteins. The risk multiplication is real and clinically significant.

F5 Factor V Leiden

Summary

Genotype spectrum

Practical takeaway

Evidence detail

Sources (8)